Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Commercial Officer
-
Issuer Symbol
-
HCAT on Nasdaq
There are no Buy or Sell transactions made by Kevin Lee Freeman since 29 Dec 2024
Holdings reported by Kevin Lee Freeman for Health Catalyst, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
358,686 |
$1,040,261 |
$2.9 |
01 Dec 2025 |
Direct |
|
|
Transactions reported by Kevin Lee Freeman for Health Catalyst, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.